-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
Talis Biomedical Corp quarterly Deferred Tax Assets, Net of Valuation Allowance history and change rate from Q4 2020 to Q4 2023.
- Talis Biomedical Corp Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Dec 2023 was $3.67M, a 50.9% decline year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)